1. Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.
- Author
-
Pecora, Irene, Ugolini, Clara, Giannini, Riccardo, Giordano, Mirella, Vivaldi, Caterina, Lencioni, Monica, Santi, Stefano, Massa, Valentina, Pallabazzer, Giovanni, Catanese, Silvia, Salani, Francesca, Belluomini, Mario Antonio, Vasile, Enrico, Cremolini, Chiara, Fontanini, Gabriella, Masi, Gianluca, and Fornaro, Lorenzo
- Subjects
- *
THERAPEUTIC use of antineoplastic agents , *STOMACH tumors , *PERIOPERATIVE care , *FOLINIC acid , *BIOPSY , *COMPLEMENT (Immunology) , *B cells , *CANCER chemotherapy , *CELL physiology , *REGRESSION analysis , *IMMUNOLOGY technique , *SURGERY , *PATIENTS , *FLUOROURACIL , *CANCER patients , *COMPARATIVE studies , *GENE expression , *CELL cycle , *TUMOR classification , *PRE-tests & post-tests , *TREATMENT effectiveness , *DOCETAXEL , *SYMPTOMS , *TUMOR necrosis factors , *MAST cells , *RESEARCH funding , *GENE expression profiling , *OXALIPLATIN , *T cells , *LONGITUDINAL method - Abstract
Introduction: In locally advanced gastric cancer (GC), FLOT represents the standard perioperative regimen and combination with immunotherapy is under investigation. However, the role of immune tumor microenvironment (TME) is poorly recognized in this setting. We aimed to study TME characteristics and dynamics during FLOT. Methods: Paired biopsy (PRE) and surgical (POST) samples of 25 patients treated with FLOT were prospectively analyzed. After collection of clinic-pathological data, NanoString analyses were performed. The primary objective of the study was to assess the changes induced by chemotherapy in POST compared to PRE samples. Results: The unsupervised hierarchical method analysis clearly distinguished PRE and POST samples, even though some cases showed high immune gene expression at baseline. When POST samples were compared with PRE, a differential expression in hyper-expressed gene sets related to cytotoxicity, T-cell functions, complement system, tumor necrosis factor superfamily, cell cycle, and regulation was recognized. Downstaging of the primary tumor (T-regression, measured by pathologic compared to clinical T stage) was the covariate most frequently associated with these changes. Using the immune cell profiling, cases with T-regression reported a significant increase of T, CD8+ T and B cells and a decrease in mast cells, while nonresponders demonstrated an increase of T, B, cytotoxic, and mast cells. Conclusion: Our analysis shows that FLOT significantly influences immune TME of GC. While relevant modifications preferentially occur in tumors showing primary tumor regression, response to treatment seems to be associated with a specific immune profile. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF